While available in only a few countries, home therapy is a possible strategy for the treatment of alpha-1 antitrypsin deficiency. We want to describe our experience in the management of human alpha-1 antitrypsin using home care intravenous augmentation therapy during this emergency period caused by SARS-CoV2 infection. We assessed the safety of the home treatment and the quality of life of patients enrolled in the program.
Annunziata, A., Lanza, M., Coppola, A., Andreozzi, P., Spinelli, S., & Fiorentino, G. (2021). Alpha-1 Antitrypsin Deficiency: Home Therapy. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.575402